Nuwellis, Inc.

Nuwellis, Inc. company information, Employees & Contact Information

Updated June 2026

Quick answer

Nuwellis, Inc. is a Medical Equipment Manufacturing company. It has approximately 62 employees on record. Contact data was last refreshed in June 2026. Find Nuwellis, Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Restoring Fluid Balance. Renewing Hope. Nuwellis (Nasdaq: NUWE) is a medical technology company dedicated to improving the lives of patients with fluid overload—a common and serious complication of heart failure, critical illness, and other complex conditions. Our Aquadex SmartFlow® system provides clinicians with a precise, safe, and flexible way to remove excess fluid, helping restore balance and support recovery. Designed for use in patients weighing 20 kg or more, Aquadex is used across hospital settings to improve outcomes when fluid management becomes a challenge. Headquartered in Eden Prairie, Minnesota, with a wholly owned subsidiary in Ireland, Nuwellis has been publicly traded on the Nasdaq Capital Market since 2012. We are a purpose-driven team focused on clinical impact, meaningful innovation, and supporting the care teams who make better outcomes possible. Learn more at nuwellis.com

Company Details

Employees
62
Address
12988 Valley View Rd, Eden Prairie,minnesota 55344,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Eden Prairie, Minnesota
Looking for a particular Nuwellis, Inc. employee's phone or email?

Nuwellis, Inc. Questions

News

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025 - Yahoo Finance

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025 Yahoo Finance

Nuwellis, Inc. to Announce Third Quarter 2025 Financial Results on November 12, 2025 - Quiver Quantitative

Nuwellis, Inc. to Announce Third Quarter 2025 Financial Results on November 12, 2025 Quiver Quantitative

Nuwellis (Nasdaq: NUWE) to release third-quarter results Nov. 12; call at 9:00 AM ET - Stock Titan

Nuwellis (Nasdaq: NUWE) to release third-quarter results Nov. 12; call at 9:00 AM ET Stock Titan

Update on Alert: Extracorporeal Blood Circuit Issue from Nuwellis - fda.gov

Update on Alert: Extracorporeal Blood Circuit Issue from Nuwellis fda.gov

Nuwellis Stockholders Approve All Proposals at Special Meeting - Yahoo Finance

Nuwellis Stockholders Approve All Proposals at Special Meeting Yahoo Finance

Nuwellis, Inc. Stockholders Approve Key Proposals to Enhance Financial Flexibility and Support Strategic Growth - Quiver Quantitative

Nuwellis, Inc. Stockholders Approve Key Proposals to Enhance Financial Flexibility and Support Strategic Growth Quiver Quantitative

New 24-Hour Fluid Management Circuit: Nuwellis Transforms Outpatient Care with Aquadex Innovation - Stock Titan

New 24-Hour Fluid Management Circuit: Nuwellis Transforms Outpatient Care with Aquadex Innovation Stock Titan

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights - Yahoo Finance

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights Yahoo Finance

Nuwellis, Inc. Announces Positive Findings from ULTRA-Peds Registry on Aquadex Therapy for Critically Ill Children - Quiver Quantitative

Nuwellis, Inc. Announces Positive Findings from ULTRA-Peds Registry on Aquadex Therapy for Critically Ill Children Quiver Quantitative

Revolutionary Blood Safety Patent: Nuwellis's Vivian Device Could Transform Pediatric Care - Stock Titan

Revolutionary Blood Safety Patent: Nuwellis's Vivian Device Could Transform Pediatric Care Stock Titan

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter - Yahoo Finance

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter Yahoo Finance

Nuwellis, Inc. Postpones 2025 Second Quarter Earnings Release and Conference Call to August 14, 2025 - Quiver Quantitative

Nuwellis, Inc. Postpones 2025 Second Quarter Earnings Release and Conference Call to August 14, 2025 Quiver Quantitative

Nuwellis Q2 Earnings Postponed: Medical Tech Company Needs Extra Time for Audit Completion - Stock Titan

Nuwellis Q2 Earnings Postponed: Medical Tech Company Needs Extra Time for Audit Completion Stock Titan

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - Yahoo Finance

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech Yahoo Finance

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration - Yahoo Finance

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration Yahoo Finance

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company - Yahoo Finance

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company Yahoo Finance

Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio - Yahoo Finance

Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio Yahoo Finance

Nuwellis, Inc. Discusses NIH Grant for Pediatric CRRT Development in Virtual Investor Segment - Quiver Quantitative

Nuwellis, Inc. Discusses NIH Grant for Pediatric CRRT Development in Virtual Investor Segment Quiver Quantitative

Nuwellis, Inc. Secures U.S. Patent No. 12,357,734 for Innovative Blood Filtering System in Ultrafiltration Therapy - Quiver Quantitative

Nuwellis, Inc. Secures U.S. Patent No. 12,357,734 for Innovative Blood Filtering System in Ultrafiltration Therapy Quiver Quantitative

New FDA-Cleared Dual Lumen Catheter Expands Nuwellis' Fluid Management Platform for ICU to Outpatient Care - Stock Titan

New FDA-Cleared Dual Lumen Catheter Expands Nuwellis' Fluid Management Platform for ICU to Outpatient Care Stock Titan

Nuwellis, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement - Quiver Quantitative

Nuwellis, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement Quiver Quantitative

Nuwellis Expands Aquadex Treatment to Outpatient Setting with 4x Higher Reimbursement Rate - Stock Titan

Nuwellis Expands Aquadex Treatment to Outpatient Setting with 4x Higher Reimbursement Rate Stock Titan

Medical Technology Company Nuwellis to Showcase Fluid Management Solutions at Webull Investor Conference - Stock Titan

Medical Technology Company Nuwellis to Showcase Fluid Management Solutions at Webull Investor Conference Stock Titan

Critical Care Tech Expansion: Nuwellis Plans Acquisition of Rendiatech's Real-Time Kidney Monitoring System - Stock Titan

Critical Care Tech Expansion: Nuwellis Plans Acquisition of Rendiatech's Real-Time Kidney Monitoring System Stock Titan

Nuwellis, Inc. Terminates REVERSE-HF Clinical Trial to Focus on Outpatient Market Opportunities - Quiver Quantitative

Nuwellis, Inc. Terminates REVERSE-HF Clinical Trial to Focus on Outpatient Market Opportunities Quiver Quantitative

$3M NIH Grant Accelerates Development of Life-Saving Kidney Device for Children Under 20kg - Stock Titan

$3M NIH Grant Accelerates Development of Life-Saving Kidney Device for Children Under 20kg Stock Titan

Nuwellis, Inc. Raises Approximately $5.0 Million in Public Offering of Common Stock and Warrants - Nasdaq

Nuwellis, Inc. Raises Approximately $5.0 Million in Public Offering of Common Stock and Warrants Nasdaq

Revolutionary Blood Filtering Patent Positions Nuwellis to Transform CRRT Accuracy - Stock Titan

Revolutionary Blood Filtering Patent Positions Nuwellis to Transform CRRT Accuracy Stock Titan

Nuwellis Launches Complex $4.3M Public Offering with Multi-Tier Warrant Structure - Stock Titan

Nuwellis Launches Complex $4.3M Public Offering with Multi-Tier Warrant Structure Stock Titan

Nuwellis Brings Back Veteran CEO John Erb to Lead Medical Tech Innovation Push - Stock Titan

Nuwellis Brings Back Veteran CEO John Erb to Lead Medical Tech Innovation Push Stock Titan

Nuwellis Secures $5M Through Public Offering: Complete Details on Stock and Warrant Terms Revealed - Stock Titan

Nuwellis Secures $5M Through Public Offering: Complete Details on Stock and Warrant Terms Revealed Stock Titan

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care - The Manila Times

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care The Manila Times

Nuwellis Announces Reverse Stock Split - Stock Titan

Nuwellis Announces Reverse Stock Split Stock Titan

Nuwellis Announces Reverse Stock Split - MarketScreener

Nuwellis Announces Reverse Stock Split MarketScreener

Nuwellis Initiates REVERSE-HF Study to Evaluate Ultrafiltration for Heart Failure Patients with Fluid Overload - Diagnostic and Interventional Cardiology

Nuwellis Initiates REVERSE-HF Study to Evaluate Ultrafiltration for Heart Failure Patients with Fluid Overload Diagnostic and Interventional Cardiology

CHF Solutions Becomes Nuwellis Inc. - Medical Product Outsourcing

CHF Solutions Becomes Nuwellis Inc. Medical Product Outsourcing

NUWE - Nuwellis Inc Latest Stock News & Market Updates - Stock Titan

NUWE - Nuwellis Inc Latest Stock News & Market Updates Stock Titan

Top Nuwellis, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant